Gianluca Lozza

2.1k total citations
23 papers, 951 citations indexed

About

Gianluca Lozza is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Gianluca Lozza has authored 23 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Gianluca Lozza's work include Neuroscience and Neuropharmacology Research (7 papers), Adenosine and Purinergic Signaling (7 papers) and Pain Mechanisms and Treatments (4 papers). Gianluca Lozza is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Adenosine and Purinergic Signaling (7 papers) and Pain Mechanisms and Treatments (4 papers). Gianluca Lozza collaborates with scholars based in Italy, United States and United Kingdom. Gianluca Lozza's co-authors include Ennio Ongini, Angela Monopoli, Mariagrazia Grilli, A Forlani, C Casati, R. Brusa, Ilaria Barbieri, Ray A. Olsson, Yi Zhang and John C. Shryock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Gianluca Lozza

23 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianluca Lozza Italy 15 346 328 316 230 174 23 951
Edward Leung Italy 23 874 2.5× 981 3.0× 391 1.2× 148 0.6× 168 1.0× 36 1.8k
Giulia Arslan Sweden 9 365 1.1× 574 1.8× 229 0.7× 87 0.4× 57 0.3× 10 786
Eva Lindgren Sweden 22 569 1.6× 358 1.1× 373 1.2× 38 0.2× 340 2.0× 39 1.3k
Liang‐Hao Guo Germany 18 203 0.6× 178 0.5× 205 0.6× 189 0.8× 363 2.1× 25 851
Zsolt Jurányi Hungary 13 238 0.7× 193 0.6× 292 0.9× 135 0.6× 60 0.3× 35 787
Stephen V. Straub United States 14 677 2.0× 116 0.4× 456 1.4× 184 0.8× 291 1.7× 15 1.3k
Elena Meli Italy 15 353 1.0× 58 0.2× 380 1.2× 228 1.0× 72 0.4× 20 955
Maria Josè Sisalli Italy 19 546 1.6× 68 0.2× 281 0.9× 112 0.5× 144 0.8× 39 956
Timo T. Myöhänen Finland 23 729 2.1× 146 0.4× 611 1.9× 57 0.2× 140 0.8× 56 1.7k
Joel B. Schachter United States 24 860 2.5× 682 2.1× 461 1.5× 185 0.8× 783 4.5× 35 2.0k

Countries citing papers authored by Gianluca Lozza

Since Specialization
Citations

This map shows the geographic impact of Gianluca Lozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Lozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Lozza more than expected).

Fields of papers citing papers by Gianluca Lozza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Lozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Lozza. The network helps show where Gianluca Lozza may publish in the future.

Co-authorship network of co-authors of Gianluca Lozza

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Lozza. A scholar is included among the top collaborators of Gianluca Lozza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Lozza. Gianluca Lozza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tulshian, Deen, Julius J. Matasi, Qiang Li, et al.. (2012). Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22(23). 7223–7226. 8 indexed citations
2.
Burnett, Duane A., William J. Greenlee, Chad Knutson, et al.. (2012). Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(4). 1575–1578. 20 indexed citations
3.
4.
Li, Qiang, Duane A. Burnett, William J. Greenlee, et al.. (2010). A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties. Bioorganic & Medicinal Chemistry Letters. 20(8). 2474–2477. 16 indexed citations
5.
Li, Qiang, Duane A. Burnett, William J. Greenlee, et al.. (2009). Tricyclic thienopyridine–pyrimidones/thienopyrimidine–pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 19(12). 3199–3203. 26 indexed citations
6.
Downey, Patrick, Jason S. Simon, D.J. Devlin, et al.. (2008). Identification of single nucleotide polymorphisms of the human metabotropic glutamate receptor 1 gene and pharmacological characterization of a P993S variant. Biochemical Pharmacology. 77(7). 1246–1253. 6 indexed citations
7.
Wu, Wen‐Lian, Duane A. Burnett, Martin S. Domalski, et al.. (2007). Discovery of Orally Efficacious Tetracyclic Metabotropic Glutamate Receptor 1 (mGluR1) Antagonists for the Treatment of Chronic Pain. Journal of Medicinal Chemistry. 50(23). 5550–5553. 30 indexed citations
8.
Hyde, Lynn A., Tatiana M. Kazdoba, Mariagrazia Grilli, et al.. (2005). Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behavioural Brain Research. 160(2). 344–355. 68 indexed citations
9.
Downey, Patrick, Gianluca Lozza, Enrica Diodato, et al.. (2005). Ecdysone-Based System for Controlled Inducible Expression of Metabotropic Glutamate Receptor Subtypes 2, 5, and 8. SLAS DISCOVERY. 10(8). 841–848. 8 indexed citations
10.
Quarto, Micaela, et al.. (2003). Long-lasting induction of Notch2 in the hippocampus of kainate-treated adult mice. Neuroreport. 14(7). 917–921. 10 indexed citations
11.
Parker, Eric M., Angela Monopoli, Ennio Ongini, Gianluca Lozza, & Carol Babij. (2000). Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. Neuropharmacology. 39(10). 1913–1919. 35 indexed citations
12.
Grilli, Mariagrazia, Ilaria Barbieri, R. Brusa, et al.. (2000). Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage. European Journal of Neuroscience. 12(7). 2265–2272. 163 indexed citations
13.
Halldner, Linda, Gianluca Lozza, Karin Lindström, & Bertil B. Fredholm. (2000). Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist. European Journal of Pharmacology. 406(3). 345–354. 46 indexed citations
14.
Sacco, Silvano, Davide Agnello, Marcello Sottocorno, et al.. (1998). Nonsteroidal Anti‐Inflammatory Drugs Increase Tumor Necrosis Factor Production in the Periphery but Not in the Central Nervous System in Mice and Rats. Journal of Neurochemistry. 71(5). 2063–2070. 28 indexed citations
15.
Monopoli, Angela, et al.. (1998). Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport. 9(17). 3955–3958. 179 indexed citations
16.
Belardinelli, Luiz, John C. Shryock, Yi Zhang, et al.. (1998). The A2A Adenosine Receptor Mediates Coronary Vasodilation. Journal of Pharmacology and Experimental Therapeutics. 284(3). 1066–1073. 144 indexed citations
17.
Lozza, Gianluca, et al.. (1997). PROLONGED EXPOSURE TO 5′-N-ETHYLCARBOXAMIDOADENOSINE (NECA) DOES NOT AFFECT THE ADENOSINE A2A-MEDIATED VASODILATION IN PORCINE CORONARY ARTERIES. Pharmacological Research. 35(2). 123–128. 13 indexed citations
18.
Lozza, Gianluca, et al.. (1997). CARDIOPROTECTIVE EFFECTS OF ADENOSINE A1AND A2ARECEPTOR AGONISTS IN THE ISOLATED RAT HEART. Pharmacological Research. 35(1). 57–64. 34 indexed citations
19.
Casati, C, A Forlani, Gianluca Lozza, & Angela Monopoli. (1997). HEMODYNAMIC CHANGES DO NOT MEDIATE THE CARDIOPROTECTION INDUCED BY THE A1, ADENOSINE RECEPTOR AGONIST CCPA IN THE RABBIT. Pharmacological Research. 35(1). 51–55. 9 indexed citations
20.
Casati, C, et al.. (1996). Cardiovascular pharmacology of SCH 59761, a highly potent, non-selective, adenosine receptor agonist. Drug Development Research. 39(1). 1–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Leung Breakdown of academic impact, for papers by Giulia Arslan Breakdown of academic impact, for papers by Eva Lindgren Breakdown of academic impact, for papers by Liang‐Hao Guo Breakdown of academic impact, for papers by Zsolt Jurányi Breakdown of academic impact, for papers by Stephen V. Straub Breakdown of academic impact, for papers by Elena Meli Breakdown of academic impact, for papers by Maria Josè Sisalli Breakdown of academic impact, for papers by Timo T. Myöhänen Breakdown of academic impact, for papers by Joel B. Schachter
Rankless by CCL
2026